Clinical Trial Update: Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation

View source ↗

Summary

Completed clinical trial evaluating immunosuppression regimens using Myfortic, Prograf, and corticosteroids in de novo liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Drugs mentioned

• Corticosteroids (corticosteroids)
• MYFORTIC (MYCOPHENOLIC ACID)
• Prograf (Tacrolimus)

Snippet

Sponsor: R. Mark Ghobrial, MD | Conditions: End Stage Liver Disease | Status: COMPLETED